Biological Target
Ribonucleotide reductase
Biological Target
Ribonucleotide reductase Description
Ribonucleotide reductase (RNR) is a crucial enzyme complex responsible for the de novo synthesis of deoxyribonucleotides, essential precursors for DNA replication and repair. It catalyzes the conversion of ribonucleoside diphosphates into their corresponding deoxyribonucleoside diphosphates. The human RNR complex consists of two homodimeric subunits: R1 (RRM1), which contains the active site, and R2 (RRM2 or RRM2B), which generates and stores a stable tyrosyl radical necessary for catalysis, thereby representing the rate-limiting step in DNA synthesis.
Medications Targeting Ribonucleotide reductase
Hydroxyurea →
Modulator
Medication
Antineoplastic agent; Ribonucleotide reductase inhibitor
Small molecule